Literature DB >> 23125145

Molecular profiling reveals prognostically significant subtypes of canine lymphoma.

A M Frantz1, A L Sarver, D Ito, T L Phang, A Karimpour-Fard, M C Scott, V E O Valli, K Lindblad-Toh, K E Burgess, B D Husbands, M S Henson, A Borgatti, W C Kisseberth, L E Hunter, M Breen, T D O'Brien, J F Modiano.   

Abstract

We performed genomewide gene expression analysis of 35 samples representing 6 common histologic subtypes of canine lymphoma and bioinformatics analyses to define their molecular characteristics. Three major groups were defined on the basis of gene expression profiles: (1) low-grade T-cell lymphoma, composed entirely by T-zone lymphoma; (2) high-grade T-cell lymphoma, consisting of lymphoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified; and (3) B-cell lymphoma, consisting of marginal B-cell lymphoma, diffuse large B-cell lymphoma, and Burkitt lymphoma. Interspecies comparative analyses of gene expression profiles also showed that marginal B-cell lymphoma and diffuse large B-cell lymphoma in dogs and humans might represent a continuum of disease with similar drivers. The classification of these diverse tumors into 3 subgroups was prognostically significant, as the groups were directly correlated with event-free survival. Finally, we developed a benchtop diagnostic test based on expression of 4 genes that can robustly classify canine lymphomas into one of these 3 subgroups, enabling a direct clinical application for our results.

Entities:  

Keywords:  canine; gene expression profiling; lymphoma subclassification; prognostication

Mesh:

Substances:

Year:  2012        PMID: 23125145      PMCID: PMC4683027          DOI: 10.1177/0300985812465325

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  30 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

3.  Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.

Authors:  Laura D Garrett; Douglas H Thamm; Ruthanne Chun; Robert Dudley; David M Vail
Journal:  J Vet Intern Med       Date:  2002 Nov-Dec       Impact factor: 3.333

Review 4.  Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.

Authors:  Jeremy S Abramson; Margaret A Shipp
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

5.  Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.

Authors:  M J Wilkerson; K Dolce; T Koopman; W Shuman; R Chun; L Garrett; L Barber; A Avery
Journal:  Vet Immunol Immunopathol       Date:  2005-07-15       Impact factor: 2.046

6.  CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma.

Authors:  C M Jubala; J W Wojcieszyn; V E O Valli; D M Getzy; S P Fosmire; D Coffey; D Bellgrau; J F Modiano
Journal:  Vet Pathol       Date:  2005-07       Impact factor: 2.221

7.  Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach.

Authors:  Milcah C Scott; Aaron L Sarver; Katherine J Gavin; Venugopal Thayanithy; David M Getzy; Robert A Newman; Gary R Cutter; Kerstin Lindblad-Toh; William C Kisseberth; Lawrence E Hunter; Subbaya Subramanian; Matthew Breen; Jaime F Modiano
Journal:  Bone       Date:  2011-05-15       Impact factor: 4.398

8.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

9.  Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

Authors:  Stefano Monti; Kerry J Savage; Jeffery L Kutok; Friedrich Feuerhake; Paul Kurtin; Martin Mihm; Bingyan Wu; Laura Pasqualucci; Donna Neuberg; Ricardo C T Aguiar; Paola Dal Cin; Christine Ladd; Geraldine S Pinkus; Gilles Salles; Nancy Lee Harris; Riccardo Dalla-Favera; Thomas M Habermann; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2004-11-18       Impact factor: 22.113

10.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

View more
  34 in total

Review 1.  Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications.

Authors:  Daisuke Ito; Aric M Frantz; Jaime F Modiano
Journal:  Vet Immunol Immunopathol       Date:  2014-02-24       Impact factor: 2.046

2.  Primary renal lymphoma: a case report and review of the literature.

Authors:  Kai Zhao; Qijie Zhang; Rong Cong; Yamin Wang; Zengjun Wang; Ninghong Song
Journal:  AME Case Rep       Date:  2020-04-30

Review 3.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 4.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

5.  Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential.

Authors:  Daisuke Ito; Susan Brewer; Jaime F Modiano; Melissa J Beall
Journal:  Leuk Lymphoma       Date:  2014-06-16

6.  Bilateral renal T-cell lymphoma with hepatic infiltration and secondary polycythemia in a dog: Utility of cytology slides.

Authors:  Rémi Froment; Carolyn Gara-Boivin
Journal:  Can Vet J       Date:  2015-12       Impact factor: 1.008

7.  Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.

Authors:  Kristy L Richards; Alison A Motsinger-Reif; Hsiao-Wei Chen; Yuri Fedoriw; Cheng Fan; Dahlia M Nielsen; George W Small; Rachael Thomas; Chris Smith; Sandeep S Dave; Charles M Perou; Matthew Breen; Luke B Borst; Steven E Suter
Journal:  Cancer Res       Date:  2013-06-19       Impact factor: 12.701

8.  Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies.

Authors:  Eleonora Zorzan; Ramy Elgendy; Giorgia Guerra; Silvia Da Ros; Maria Elena Gelain; Federico Bonsembiante; Giulia Garaffo; Nicoletta Vitale; Roberto Piva; Laura Marconato; Luca Aresu; Mauro Dacasto; Mery Giantin
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

9.  Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).

Authors:  Manikhandan A V Mudaliar; Ross D Haggart; Gino Miele; Grant Sellar; Karen A L Tan; John R Goodlad; Elspeth Milne; David M Vail; Ilene Kurzman; Daniel Crowther; David J Argyle
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication?

Authors:  Mery Giantin; Anna Granato; Chiara Baratto; Laura Marconato; Marta Vascellari; Emanuela M Morello; Antonella Vercelli; Franco Mutinelli; Mauro Dacasto
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.